Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 201

1.

Quality, immunogenicity and stability of meningococcal serogroup ACWY-CRM197, DT and TT glycoconjugate vaccines.

Beresford NJ, Martino A, Feavers IM, Corbel MJ, Bai X, Borrow R, Bolgiano B.

Vaccine. 2017 Jun 16;35(28):3598-3606. doi: 10.1016/j.vaccine.2017.03.066. Epub 2017 Apr 10.

2.

Russian vaccines against especially dangerous bacterial pathogens.

Feodorova VA, Sayapina LV, Corbel MJ, Motin VL.

Emerg Microbes Infect. 2014 Dec;3(12):e86. doi: 10.1038/emi.2014.82. Epub 2014 Dec 17. Review.

3.

Report of an International collaborative study to establish the first WHO reference reagents for BCG vaccines of three different sub-strains.

Ho MM, Markey K, Rigsby P, Hockley J, Corbel MJ.

Vaccine. 2011 Jan 10;29(3):512-8. doi: 10.1016/j.vaccine.2010.10.066. Epub 2010 Nov 4.

PMID:
21055496
4.

Report of an international collaborative study to evaluate the suitability of multiplex PCR as an identity assay for different sub-strains of BCG vaccine.

Markey K, Ho MM, Choudhury B, Seki M, Ju L, Castello-Branco LR, Gairola S, Zhao A, Shibayama K, Andre M, Corbel MJ.

Vaccine. 2010 Oct 8;28(43):6964-9. doi: 10.1016/j.vaccine.2010.08.045. Epub 2010 Aug 21.

PMID:
20732463
5.

Prospects for new plague vaccines.

Feodorova VA, Corbel MJ.

Expert Rev Vaccines. 2009 Dec;8(12):1721-38. doi: 10.1586/erv.09.129. Review. Erratum in: Expert Rev Vaccines. 2010 Jan;9(1):110.

PMID:
19943765
6.

Vaccines and biosimilarity: a solution or a problem?

Corbel MJ, Cortes Castillo Mde L.

Expert Rev Vaccines. 2009 Oct;8(10):1439-49. doi: 10.1586/erv.09.97. Review.

PMID:
19803764
7.

Current progress with Moraxella catarrhalis antigens as vaccine candidates.

Mawas F, Ho MM, Corbel MJ.

Expert Rev Vaccines. 2009 Jan;8(1):77-90. doi: 10.1586/14760584.8.1.77. Review.

PMID:
19093775
8.

Transferability of dermal temperature histamine sensitization test for estimation of pertussis toxin activity in vaccines.

Gaines-Das R, Ochiai M, Douglas-Bardsley A, Asokanathan C, Horiuchi Y, Rigsby P, Corbel MJ, Xing DK.

Hum Vaccin. 2009 Mar;5(3):166-71. Epub 2009 Mar 15.

PMID:
18758243
9.

Report of an international collaborative study to establish the suitability of using modified ATP assay for viable count of BCG vaccine.

Ho MM, Markey K, Rigsby P, Jensen SE, Gairola S, Seki M, Castello-Branco LR, López-Vidal Y, Knezevic I, Corbel MJ.

Vaccine. 2008 Aug 26;26(36):4754-7. doi: 10.1016/j.vaccine.2008.06.026. Epub 2008 Jun 27.

PMID:
18586063
10.

WHO Working Group on revision of the Manual of Laboratory Methods for Testing DTP Vaccines-Report of two meetings held on 20-21 July 2006 and 28-30 March 2007, Geneva, Switzerland.

Corbel MJ, Das RG, Lei D, Xing DK, Horiuchi Y, Dobbelaer R; WHO Working Group.

Vaccine. 2008 Apr 7;26(16):1913-21. doi: 10.1016/j.vaccine.2008.02.013. Epub 2008 Feb 21.

PMID:
18336960
11.

Perspectives for the treatment of brucellosis in the 21st century: the Ioannina recommendations.

Ariza J, Bosilkovski M, Cascio A, Colmenero JD, Corbel MJ, Falagas ME, Memish ZA, Roushan MR, Rubinstein E, Sipsas NV, Solera J, Young EJ, Pappas G; International Society of Chemotherapy; Institute of Continuing Medical Education of Ioannina.

PLoS Med. 2007 Dec;4(12):e317. No abstract available.

12.

A retrospective study on the quality of Haemophilus influenzae type b vaccines used in the UK between 1996 and 2004.

Bolgiano B, Mawas F, Burkin K, Crane DT, Saydam M, Rigsby P, Corbel MJ.

Hum Vaccin. 2007 Sep-Oct;3(5):176-82. Epub 2007 Apr 27.

PMID:
17786035
13.

Physico-chemical characterisation and immunogenicity of a multi-valent candidate vaccine against non-typeable Haemophilus influenzae and Moraxella catarrhalis.

Mawas F, Ho MM, Huskisson R, Saydam M, Corbel MJ.

Vaccine. 2007 Jun 15;25(25):4801-8. Epub 2007 Apr 25.

PMID:
17507119
14.

WHO working group on standardisation and control of acellular pertussis vaccines--report of a meeting held on 16-17 March 2006, St. Albans, United Kingdom.

Xing DK, Corbel MJ, Dobbelaer R, Knezevic I.

Vaccine. 2007 Apr 12;25(15):2749-57. Epub 2006 Sep 29.

PMID:
17368348
15.

Evaluation of the saccharide content and stability of the first WHO International Standard for Haemophilus influenzae b capsular polysaccharide.

Mawas F, Bolgiano B, Rigsby P, Crane D, Belgrave D, Corbel MJ.

Biologicals. 2007 Oct;35(4):235-45. Epub 2007 Mar 6.

PMID:
17337205
16.

ADP-ribosylation activity in pertussis vaccines and its relationship to the in vivo histamine-sensitisation test.

Gomez SR, Yuen CT, Asokanathan C, Douglas-Bardsley A, Corbel MJ, Coote JG, Parton R, Xing DK.

Vaccine. 2007 Apr 30;25(17):3311-8. Epub 2007 Jan 19.

PMID:
17287049
17.

Preclinical laboratory evaluation of a bivalent Staphylococcus aureus saccharide-exotoxin A protein conjugate vaccine.

Ho MM, Bolgiano B, Martino A, Kairo SK, Corbel MJ.

Hum Vaccin. 2006 May-Jun;2(3):89-98. Epub 2006 May 23.

PMID:
17012902
18.
19.

Investigation in a model system of the effects of combinations of anthrax and pertussis vaccines administered to service personnel in the 1991 Gulf War.

Rijpkema SG, Adams T, Rigsby P, Xing DK, Corbel MJ.

Hum Vaccin. 2005 Jul-Aug;1(4):165-9. Epub 2005 Jul 1.

PMID:
17012879
20.
21.

Effect of different forms of adenylate cyclase toxin of Bordetella pertussis on protection afforded by an acellular pertussis vaccine in a murine model.

Cheung GY, Xing D, Prior S, Corbel MJ, Parton R, Coote JG.

Infect Immun. 2006 Dec;74(12):6797-805. Epub 2006 Sep 18.

22.

Development of a carbohydrate binding assay for the B-oligomer of pertussis toxin and toxoid.

Gomez SR, Xing DK, Corbel MJ, Coote J, Parton R, Yuen CT.

Anal Biochem. 2006 Sep 15;356(2):244-53. Epub 2006 Jun 5.

PMID:
16782039
23.

WHO discussion on the improvement of the quality control of BCG vaccines. Pasteur Institute, Paris, France, 7 June 2005.

Knezevic I, Corbel MJ.

Vaccine. 2006 May 1;24(18):3874-7. No abstract available.

PMID:
16755681
24.

Evaluation of adenyl cyclase toxin constructs from Bordetella pertussis as candidate vaccine components in an in vitro model of complement-dependent intraphagocytic killing.

Prior S, Fleck RA, Gillett ML, Rigsby PR, Corbel MJ, Stacey GN, Xing DK.

Vaccine. 2006 May 29;24(22):4794-803. Epub 2006 Apr 3.

PMID:
16675078
25.

Immune interaction between components of acellular pertussis-diphtheria-tetanus (DTaP) vaccine and Haemophilus influenzae b (Hib) conjugate vaccine in a rat model.

Mawas F, Dickinson R, Douglas-Bardsley A, Xing DK, Sesardic D, Corbel MJ.

Vaccine. 2006 Apr 24;24(17):3505-12. Epub 2006 Feb 23.

PMID:
16524648
26.

A review of WHO International Standards for botulinum antitoxins.

Jones RG, Corbel MJ, Sesardic D.

Biologicals. 2006 Sep;34(3):223-6. Epub 2006 Feb 20. Review.

PMID:
16490362
28.

Control and lot release of meningococcal group C conjugate vaccines.

Suker J, Feavers IM, Corbel MJ, Jones C, Bolgiano B.

Expert Rev Vaccines. 2004 Oct;3(5):533-40. Review.

PMID:
15485333
29.

Characterisation of adsorbed anthrax vaccine by two-dimensional gel electrophoresis.

Whiting GC, Rijpkema S, Adams T, Corbel MJ.

Vaccine. 2004 Oct 22;22(31-32):4245-51.

PMID:
15474715
30.

Report on a WHO consultation on the characterisation of BCG strains, Imperial College, London 15-16 December 2003.

Corbel MJ, Fruth U, Griffiths E, Knezevic I.

Vaccine. 2004 Jul 29;22(21-22):2675-80. No abstract available.

PMID:
15309814
31.

Determination of serum antibody to Bordetella pertussis adenylate cyclase toxin in vaccinated and unvaccinated children and in children and adults with pertussis.

Cherry JD, Xing DX, Newland P, Patel K, Heininger U, Corbel MJ.

Clin Infect Dis. 2004 Feb 15;38(4):502-7. Epub 2004 Jan 29.

PMID:
14765342
32.

Toxicity and potency evaluation of pertussis vaccines.

Corbel MJ, Xing DK.

Expert Rev Vaccines. 2004 Feb;3(1):89-101. Review.

PMID:
14761246
33.

WHO Working Group on the standardisation and control of pertussis vaccines-report of a meeting held on 6-7 May 2003, Ferney Voltaire, France.

Corbel MJ, Kreeftenberg JG, Knezevic I.

Vaccine. 2004 Jan 2;22(3-4):293-300. No abstract available.

PMID:
14670307
34.

Novel configurations of high molecular weight species of the pertussis toxin vaccine component.

Fowler S, Byron O, Jumel K, Xing D, Corbel MJ, Bolgiano B.

Vaccine. 2003 Jun 2;21(19-20):2678-88.

PMID:
12744905
35.

Modifications of the catalytic and binding subunits of pertussis toxin by formaldehyde: effects on toxicity and immunogenicity.

Fowler S, Xing DK, Bolgiano B, Yuen CT, Corbel MJ.

Vaccine. 2003 Jun 2;21(19-20):2329-37.

PMID:
12744863
36.

Evaluation of the toxicity of recombinant Bordetella pertussis adenylate cyclase toxin preparations.

Prior S, Xing DK, Auda G, Corbel MJ.

Dev Biol (Basel). 2002;111:117-27. No abstract available.

PMID:
12678231
37.

Detection of residual pertussis toxin in vaccines using a modified ribosylation assay.

Yuen CT, Canthaboo C, Menzies JA, Cyr T, Whitehouse LW, Jones C, Corbel MJ, Xing D.

Vaccine. 2002 Nov 22;21(1-2):44-52.

PMID:
12443661
38.

Brucellosis vaccines: past, present and future.

Schurig GG, Sriranganathan N, Corbel MJ.

Vet Microbiol. 2002 Dec 20;90(1-4):479-96. Review.

PMID:
12414166
39.

Physico-chemical and immunological examination of the thermal stability of tetanus toxoid conjugate vaccines.

Ho MM, Mawas F, Bolgiano B, Lemercinier X, Crane DT, Huskisson R, Corbel MJ.

Vaccine. 2002 Oct 4;20(29-30):3509-22.

PMID:
12297396
40.
41.

Investigation of role of nitric oxide in protection from Bordetella pertussis respiratory challenge.

Canthaboo C, Xing D, Wei XQ, Corbel MJ.

Infect Immun. 2002 Feb;70(2):679-84.

42.

Fimbrial typing of Bordetella pertussis isolates: agglutination with polyclonal and monoclonal antibodies.

Xing DK, Ramakrishnan S, Newland P, Corbel MJ.

J Clin Microbiol. 2001 Nov;39(11):4220. No abstract available.

43.

Ad hoc Working Group on acellular pertussis vaccines, World Health Organisation, Geneva, 27-28 July 2000.

Corbel MJ, Mastrantonio P, Kreeftenberg JG.

Vaccine. 2001 Nov 12;20(3-4):288-91. No abstract available.

PMID:
11672887
44.
45.

Modulation of the serological response to meningococcal polysaccharides by cytokines.

Cortes-Castillo MA, Thorpe R, Corbel MJ.

Vaccine. 2001 Jul 20;19(30):4194-203.

PMID:
11457545
46.

Effect of physico-chemical modification on the immunogenicity of Haemophilus influenzae type b oligosaccharide-CRM(197) conjugate vaccines.

Bolgiano B, Mawas F, Yost SE, Crane DT, Lemercinier X, Corbel MJ.

Vaccine. 2001 Apr 30;19(23-24):3189-200.

PMID:
11312015
47.

Solution stability studies of the subunit components of meningococcal C oligosaccharide-CRM197 conjugate vaccines.

Ho MM, Lemercinier X, Bolgiano B, Crane D, Corbel MJ.

Biotechnol Appl Biochem. 2001 Apr;33(Pt 2):91-8.

PMID:
11277861
48.

Monitoring of diphtheria, pertussis and tetanus toxoids by circular dichroism, fluorescence spectroscopy and size-exclusion chromatography.

Bolgiano B, Fowler S, Turner K, Sesardic D, Xing DK, Crane DT, Corbel MJ.

Dev Biol (Basel). 2000;103:51-9.

PMID:
11214253
49.

Supplemental Content

Loading ...
Support Center